• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病年轻患者的心血管危险因素控制不充分。

Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.

作者信息

Christiansen Morten Krogh, Jensen Jesper Møller, Brøndberg Anders Krogh, Bøtker Hans Erik, Jensen Henrik Kjærulf

机构信息

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Vasc Health Risk Manag. 2016 May 25;12:219-27. doi: 10.2147/VHRM.S106436. eCollection 2016.

DOI:10.2147/VHRM.S106436
PMID:27307744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4888858/
Abstract

BACKGROUND

Control of cardiovascular risk factor is important in secondary prevention of coronary artery disease (CAD) but it is unknown whether treatment targets are achieved in young patients. We aimed to examine the prevalence and control of risk factors in this subset of patients.

METHODS

We performed a cross-sectional, single-center study on patients with documented CAD before age 40. All patients treated between 2002 and 2014 were invited to participate at least 6 months after the last coronary intervention. We included 143 patients and recorded the family history of cardiovascular disease, physical activity level, smoking status, body mass index, waist circumference, blood pressure, cholesterol levels, metabolic status, and current medical therapy. Risk factor control and treatment targets were evaluated according to the shared guidelines from the European Society of Cardiology.

RESULTS

The most common insufficiently controlled risk factors were overweight (113 [79.0%]), low-density lipoprotein cholesterol above target (77 [57.9%]), low physical activity level (78 [54.6%]), hypertriglyceridemia (67 [46.9%]), and current smoking (53 [37.1%]). Almost one-half of the patients fulfilled the criteria of metabolic syndrome. The median (interquartile range) number of uncontrolled modifiable risk factors was 2 (2;4) and only seven (4.9%) patients fulfilled all modifiable health measure targets.

CONCLUSION

Among the youngest patients with CAD, there remains a potential to improve the cardiovascular risk profile.

摘要

背景

控制心血管危险因素在冠状动脉疾病(CAD)的二级预防中很重要,但年轻患者是否能达到治疗目标尚不清楚。我们旨在研究这一亚组患者中危险因素的患病率及控制情况。

方法

我们对40岁之前确诊为CAD的患者进行了一项横断面单中心研究。邀请了2002年至2014年间接受治疗的所有患者在最后一次冠状动脉介入治疗至少6个月后参与研究。我们纳入了143例患者,并记录了心血管疾病家族史、身体活动水平、吸烟状况、体重指数、腰围、血压、胆固醇水平、代谢状况和当前的药物治疗情况。根据欧洲心脏病学会的共同指南评估危险因素控制情况和治疗目标。

结果

控制不足最常见的危险因素是超重(113例[79.0%])、低密度脂蛋白胆固醇高于目标值(77例[57.9%])、身体活动水平低(78例[54.6%])、高甘油三酯血症(67例[46.9%])和当前吸烟(53例[37.1%])。几乎一半的患者符合代谢综合征标准。未控制的可改变危险因素的中位数(四分位间距)为2(2;4),只有7例(4.9%)患者达到了所有可改变健康指标的目标。

结论

在最年轻的CAD患者中,改善心血管风险状况仍有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/f433cc9fc2d2/vhrm-12-219Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/c6f189efe5a4/vhrm-12-219Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/1b189bc9c1bf/vhrm-12-219Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/f433cc9fc2d2/vhrm-12-219Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/c6f189efe5a4/vhrm-12-219Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/1b189bc9c1bf/vhrm-12-219Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36f/4888858/f433cc9fc2d2/vhrm-12-219Fig3.jpg

相似文献

1
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.冠心病年轻患者的心血管危险因素控制不充分。
Vasc Health Risk Manag. 2016 May 25;12:219-27. doi: 10.2147/VHRM.S106436. eCollection 2016.
2
The assessment of coronary heart disease risk factors correlated with demographic and social data in post-coronary intervention patients in Polish population.波兰人群中冠状动脉介入治疗后患者冠心病危险因素与人口统计学和社会数据的相关性评估。
Cardiol J. 2015;22(3):276-84. doi: 10.5603/CJ.a2015.0021.
3
Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).颈动脉血运重建内膜切除术与支架置入术试验(CREST)中的血管危险因素管理
J Am Heart Assoc. 2014 Nov 26;3(6):e001180. doi: 10.1161/JAHA.114.001180.
4
A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: The CUT-IT trial.一项比较有氧运动与体重减轻对超重冠心病患者影响的随机试验:CUT-IT试验。
Eur J Prev Cardiol. 2015 Aug;22(8):1009-17. doi: 10.1177/2047487314545280. Epub 2014 Jul 31.
5
The MAURO study: baseline characteristics and compliance with guidelines targets.MAURO 研究:基线特征和对指南目标的依从性。
J Nephrol. 2012 Nov-Dec;25(6):1081-90. doi: 10.5301/jn.5000239.
6
Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.高血压患者的胆固醇目标达标情况:代谢综合征成分的影响。
Metab Syndr Relat Disord. 2012 Jun;10(3):195-201. doi: 10.1089/met.2011.0133. Epub 2012 Feb 7.
7
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
8
Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.心肌梗死、卒中和糖尿病诊断后的可改变心血管风险因素(血压和血脂)的药物治疗管理:俄罗斯和挪威基于人群的研究比较。
BMC Cardiovasc Disord. 2020 May 19;20(1):234. doi: 10.1186/s12872-020-01513-1.
9
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact.稳定型冠状动脉疾病患者的低密度脂蛋白胆固醇治疗目标达标情况:决定因素和预后影响。
Arch Cardiovasc Dis. 2018 Nov;111(11):634-643. doi: 10.1016/j.acvd.2017.07.007. Epub 2017 Dec 2.
10
Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.法国冠心病患者低密度脂蛋白胆固醇目标未达最佳水平。来自DYSIS II ACS/CHD研究的当代数据。
Arch Cardiovasc Dis. 2017 Mar;110(3):167-178. doi: 10.1016/j.acvd.2016.11.004. Epub 2017 Feb 13.

引用本文的文献

1
LipidSnapshot - Treatment gaps in hypercholesterolemia in patients with atherosclerotic cardiovascular disease documented by office-based cardiologists and general practitioners in Germany.脂质快照——德国办公室心脏病专家和全科医生记录的动脉粥样硬化性心血管疾病患者高胆固醇血症的治疗差距。
Clin Res Cardiol. 2025 Aug 28. doi: 10.1007/s00392-025-02751-z.
2
Myocardial Infarction in the Young: Aetiology, Emerging Risk Factors, and the Role of Novel Biomarkers.青年人心肌梗死:病因、新出现的危险因素及新型生物标志物的作用
J Cardiovasc Dev Dis. 2025 Apr 10;12(4):148. doi: 10.3390/jcdd12040148.
3
The Effect of Sleep Quality on Coronary Lesion Severity and Prognosis in the Young Acute Coronary Syndrome Population.

本文引用的文献

1
Risk factor burden and control at the time of admission in patients with acute myocardial infarction: Results from the NCDR.急性心肌梗死患者入院时的危险因素负担及控制情况:美国国家心血管数据注册研究(NCDR)的结果
Am Heart J. 2015 Jul;170(1):173-9, 179.e1. doi: 10.1016/j.ahj.2015.04.021. Epub 2015 Apr 24.
2
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.他汀类药物相关肌肉症状:对他汀类药物治疗的影响——欧洲动脉粥样硬化学会关于评估、病因及管理的共识专家组声明
Eur Heart J. 2015 May 1;36(17):1012-22. doi: 10.1093/eurheartj/ehv043. Epub 2015 Feb 18.
3
睡眠质量对年轻急性冠脉综合征人群冠状动脉病变严重程度及预后的影响
J Cardiovasc Dev Dis. 2024 Feb 19;11(2):68. doi: 10.3390/jcdd11020068.
4
RISK FACTOR DISTRIBUTION AND LONG-TERM OUTCOMES IN YOUNG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN MACEDONIA.马其顿接受经皮冠状动脉介入治疗的年轻患者的危险因素分布及长期预后
Acta Clin Croat. 2019 Dec;58(4):583-589. doi: 10.20471/acc.2019.58.04.03.
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
4
Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study.男性心肌梗死一级预防中的低危饮食和生活方式习惯:基于人群的前瞻性队列研究。
J Am Coll Cardiol. 2014 Sep 30;64(13):1299-306. doi: 10.1016/j.jacc.2014.06.1190.
5
Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention.择期冠状动脉或外周经皮介入治疗患者的风险因素控制不佳。
Am Heart J. 2014 Sep;168(3):310-316.e3. doi: 10.1016/j.ahj.2014.05.011. Epub 2014 Jun 2.
6
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.基于心血管风险的降压治疗:一项个体患者数据分析的荟萃分析。
Lancet. 2014 Aug 16;384(9943):591-598. doi: 10.1016/S0140-6736(14)61212-5.
7
Burden of sudden cardiac death in persons aged 1 to 49 years: nationwide study in Denmark.1 至 49 岁人群中心脏性猝死负担:丹麦全国性研究。
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):205-11. doi: 10.1161/CIRCEP.113.001421. Epub 2014 Mar 6.
8
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.他汀类药物不良反应和不耐受的诊断、预防和管理:加拿大工作组共识更新。
Can J Cardiol. 2013 Dec;29(12):1553-68. doi: 10.1016/j.cjca.2013.09.023. Epub 2013 Sep 29.
9
Discontinuation of statins in routine care settings: a cohort study.常规护理环境中停止使用他汀类药物:一项队列研究。
Ann Intern Med. 2013 Apr 2;158(7):526-34. doi: 10.7326/0003-4819-158-7-201304020-00004.
10
Risk factor control for coronary artery disease secondary prevention in large randomized trials.大型随机试验中冠心病二级预防的危险因素控制。
J Am Coll Cardiol. 2013 Apr 16;61(15):1607-15. doi: 10.1016/j.jacc.2013.01.044.